RESMED INC — Director's Dealing 2020

Nov 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2020-11-11

Reporting Person: Hollingshead James (President, Sleep Business)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-11	ResMed Common Stock	F	2135	$212.11	Disposed	85524	Direct
2020-11-11	ResMed Common Stock	F	1804	$212.11	Disposed	83720	Direct
2020-11-11	ResMed Common Stock	F	1286	$212.11	Disposed	82434	Direct

Footnotes

F1: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017.

F2: Includes 56.52 shares of ResMed stock purchased on October 31, 2020, through the ResMed Employee Stock Purchase Plan.

F3: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018.

F4: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/21/2019.